Galway-based Mirai Medical secures financing ahead of seeking FDA approval
Medtech company intends to raise a further €20m in a Series A funding round later this year as it looks to bring its ePore system to market
Mirai Medical, a medtech company pioneering an energy technology for use in the treatment of cancer, has secured €4 million in funding.
Speaking to the Business Post, the company’s founder, Declan Soden, said the new financing would be used to help Mirai secure FDA approval for its systems.
He said Mirai will seek to raise an additional €20 million in a Series A round later this year as it seeks to bring its flagship solution to market.
